Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Montgomery

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
International Clinical Psychopharmacology|March 15, 2013
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacyMichael E Thase, Stuart Montgomery, George I Papakostas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter studyDaniel Souery, Pierre Oswald, Isabelle Massat, et al.
The International Journal of Neuropsychopharmacology|October 5, 2017
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter StudyAlexandra Schosser, Laura Carlberg, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
The Journal of Clinical Psychiatry|January 10, 2017
A New Prediction Model for Evaluating Treatment-Resistant DepressionAlexander Kautzky, Pia Baldinger-Melich, Georg S Kranz, et al.
Comprehensive Psychiatry|October 26, 2013
Family history of major depression and residual symptoms in responder and non-responder depressed patientsAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Journal of Affective Disorders|November 20, 2020
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depressionChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 27, 2025
Symptom networks in major depressive disorder and treatment response: special focus on TRDAlexander Kautzky, Lucie Bartova, Markus Dold, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III SampleAlexander Kautzky, Markus Dold, Lucie Bartova, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
International Clinical Psychopharmacology|March 15, 2013
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacyMichael E Thase, Stuart Montgomery, George I Papakostas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2023
Age as a moderating factor of treatment resistance in depressionAlexander Kautzky, Lucie Bartova, Gernot Fugger, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter studyDaniel Souery, Pierre Oswald, Isabelle Massat, et al.
The International Journal of Neuropsychopharmacology|October 5, 2017
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter StudyAlexandra Schosser, Laura Carlberg, Raffaella Calati, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 26, 2019
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practiceLucie Bartova, Markus Dold, Alexander Kautzky, et al.
The Journal of Clinical Psychiatry|January 10, 2017
A New Prediction Model for Evaluating Treatment-Resistant DepressionAlexander Kautzky, Pia Baldinger-Melich, Georg S Kranz, et al.
Comprehensive Psychiatry|October 26, 2013
Family history of major depression and residual symptoms in responder and non-responder depressed patientsAlessandro Serretti, Alberto Chiesa, Raffaella Calati, et al.
Journal of Affective Disorders|November 20, 2020
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depressionChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 27, 2025
Symptom networks in major depressive disorder and treatment response: special focus on TRDAlexander Kautzky, Lucie Bartova, Markus Dold, et al.
The Journal of Clinical Psychiatry|December 12, 2017
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III SampleAlexander Kautzky, Markus Dold, Lucie Bartova, et al.
Pageof 12